Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05750654 · ClinicalTrials.gov registry record · NA

Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia

A NA study of Anemia, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
688
Enrollment target
1
Study location

NCT05750654: Recruiting NA study of Anemia, sponsored by The University of Texas Health Science Center, Houston.

NCT05750654 is a NA study of Anemia that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 688 participants, above the 418-participant average among 72 other Anemia trials with a reported enrollment target (65% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05750654, a NA study of Anemia, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
688 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effectiveness of small phlebotomy tubes to reduce RBC transfusions in medical intensive care unit (ICU) and Intermediate care unit (IMU) patients with low hemoglobin compared with standard size tubes, to compare the intervention and the control groups in regards to: ICU length of stay (LOS), ICU mortality, hospital LOS, and hospital mortality and to assess the acceptability of small phlebotomy tubes in adult ICU and IMU patients.

Conditions Studied

Interventions

  • DEVICE Small Phlebotomy Tube Group
  • DEVICE Standard Phlebotomy Tube Group

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 688 participants
Start Date 2023-07-24
Est. Completion 2026-01-31
Phase NA

What NCT05750654 shows while recruiting

NCT05750654 is an interventional study that assigns participants to a tested intervention. The registered 688 participants enrollment target is mid-sized for trials with a published cap, above the 418-participant average among 72 other Anemia trials with a reported enrollment target (65% higher).

The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 2 interventions - of which Small Phlebotomy Tube Group is the first listed.

NCT05750654 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05750654 about?

NCT05750654 is a clinical study titled "Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia". The purpose of this study is to evaluate the effectiveness of small phlebotomy tubes to reduce RBC transfusions in medical intensive care unit (ICU) and Intermediate care unit (IMU) patients with low hemoglobin compared with standard size tubes, to compare the intervention and the control groups in ...

What is the current status of trial NCT05750654?

This trial is currently recruiting. It is a NA study. The enrollment target is 688 participants. The study started on 2023-07-24. Estimated completion is 2026-01-31.

What conditions does trial NCT05750654 study?

This clinical trial studies the following conditions: Anemia.

What interventions are being tested in trial NCT05750654?

The interventions under investigation include: Small Phlebotomy Tube Group (DEVICE), Standard Phlebotomy Tube Group (DEVICE).

Who is sponsoring clinical trial NCT05750654?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05750654 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05750654's enrollment target sits among peer trials

688 12th of 72 higher than 61 of 72 other Anemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00532051 · 690 participants

    Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography

  • NCT05184335 · 690 participants · Phase 3

    Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

  • NCT07221149 · 690 participants · Phase 2

    A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

  • NCT04333537 · 686 participants · Phase 2

    Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05750654, the US trial registry maintained by the National Library of Medicine. NCT05750654 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.